Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Bimekizumab effectively treated a man's chronic beard hair loss.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Gefitinib can cause hair and eyebrow darkening.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Polymeric nanoparticles show promise for treating skin diseases.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Oncology specialists are disappointed by the discontinuation of the effective lymphoma treatment Bexxar.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Tofacitinib helped a woman regrow hair with no major side effects.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Axitinib treatment turned a man's grey hair back to black.

Cancer treatments often cause skin, nail, and hair problems.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

The rash resolved after stopping ponatinib.

CTP-543 is generally safe for treating alopecia areata.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

A man developed alopecia areata after starting cancer treatment with vandetanib.

Tofacitinib might be used to treat hair loss.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Tofacitinib helped regrow hair in a woman with alopecia areata.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Sonidegib is effective and safe for treating advanced basal cell carcinoma, but biopsies are needed to confirm tumor clearance.